RYTHM (RYM) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for August 12, 2024, with virtual participation and voting options available by internet, phone, or mail.
Six key proposals up for shareholder vote, including director elections, auditor ratification, reverse stock split, warrant amendments, equity plan amendment, and potential adjournment.
Board recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Election of five directors for one-year terms.
Ratification of Matsuura as independent auditor for fiscal year ending December 31, 2024.
Approval of a reverse stock split at a ratio between 1-for-2 and 1-for-20, with the final ratio and timing at the Board's discretion.
Approval to amend pre-funded warrants to increase shares underlying such warrants upon certain equity issuances, as required by Nasdaq rules.
Amendment to the 2022 Omnibus Equity Incentive Plan to increase available shares by 2,500,000.
Authorization to adjourn the meeting to solicit additional proxies if needed.
Board of directors and corporate governance
Board consists of five directors, with a majority deemed independent under Nasdaq standards.
Four standing committees: Nominating and Corporate Governance, Compensation, Audit, and Mergers and Acquisitions.
Committee charters and code of conduct are available on the company website.
Board diversity matrix and director qualifications reviewed annually.
Chairman and CEO roles are currently combined.
Latest events from RYTHM
- Q4 revenue up 164% with 75% gross margin; regulatory risks persist for hemp-derived THC.RYM
Q4 20253 Mar 2026 - Regulatory changes threaten the future of a $100M hemp-THC brand offering.RYM
Registration Filing16 Dec 2025 - Shelf registration enables up to $100M in securities for growth, with focus on hemp-derived brands.RYM
Registration Filing16 Dec 2025 - Shareholders to vote on director elections, auditor ratification, and equity plan amendment.RYM
Proxy Filing1 Dec 2025 - Key votes include director elections, reverse stock split, and major equity plan amendments.RYM
Proxy Filing1 Dec 2025 - Quorum for the August 2024 Annual Meeting is now one-third of outstanding shares.RYM
Proxy Filing1 Dec 2025 - Equity line offering seeks up to $15M amid financial challenges and industry risks.RYM
Registration Filing29 Nov 2025 - Registering 4.7M shares for resale to raise up to $15M amid ongoing losses and dilution risk.RYM
Registration Filing28 Nov 2025 - Q3 2025 revenue hit $4.0M, nearly doubling sequentially as THC beverages expanded in retail.RYM
Q3 20257 Nov 2025